Filing Flows

Filing Flows › Comparisons › AYTU vs ENTA

Aytu Biopharma vs Enanta Pharmaceuticals: AYTU and ENTA compared

Aytu Biopharma is the larger company: $16.1M of revenue in its latest quarter (Q4 FY26) against $14.4M for Enanta Pharmaceuticals (Q3 FY26). Aytu Biopharma is growing faster (+6% against -22% a year earlier). Aytu Biopharma is more profitable, with an operating margin of -4.8% against -120.0%.

Aytu Biopharma vs Enanta Pharmaceuticals, latest quarterAytu Biopharma vs Enanta Pharmaceuticals, latest quarterAytu Biopharma (AYTU)Enanta Pharmaceuticals (ENTA)Revenue$16.1M$14.4MRevenue growth, Y/Y+6%-22%Operating margin-4.8%-120.0%Net margin-0.1%-135.8%

Where the money goes: AYTU and ENTA

Aytu Biopharma (AYTU) · Q4 FY26

Aytu Biopharma, Q4 FY26: revenue $16.1M (+6% year over year), operating margin -4.8%, net loss $15K, operating cash flow $4.4M. The chart follows the revenue to costs, profit and cash.

Enanta Pharmaceuticals (ENTA) · Q3 FY26

Enanta Pharmaceuticals, Q3 FY26: revenue $14.4M (-22% year over year), operating margin -120.0%, net loss $19.5M, operating cash flow −$10.0M. The chart follows the revenue to costs, profit and cash.

Aytu Biopharma (AYTU)Enanta Pharmaceuticals (ENTA)
Latest quarterQ4 FY26Q3 FY26
Revenue$16.1M$14.4M
Revenue growth, Y/Y+6%-22%
Operating margin-4.8%-120.0%
Net earnings−$15K−$19.5M
Net margin-0.1%-135.8%
Operating cash flow$4.4M−$10.0M
Free cash flow$4.4M—

Questions

Which is bigger, Aytu Biopharma or Enanta Pharmaceuticals?

Aytu Biopharma is the larger company: $16.1M of revenue in its latest quarter (Q4 FY26) against $14.4M for Enanta Pharmaceuticals (Q3 FY26).

Is Aytu Biopharma or Enanta Pharmaceuticals growing faster?

Aytu Biopharma is growing faster (+6% against -22% a year earlier).

Which is more profitable, Aytu Biopharma or Enanta Pharmaceuticals?

Aytu Biopharma is more profitable, with an operating margin of -4.8% against -120.0%.

More: Aytu Biopharma earnings · how Aytu Biopharma makes money · Enanta Pharmaceuticals earnings · how Enanta Pharmaceuticals makes money

From the companies' latest 10-Q, 10-K or earnings release (10-K filed Sep 22, 2026; 10-Q filed Aug 12, 2026). Fiscal quarters can end on different dates. Not investment advice.